Results 181 to 190 of about 55,224 (274)

A phase 1 study of ASTX727 plus talazoparib in patients with triple‐negative or hormone resistant/HER2‐negative metastatic breast cancer

open access: yesCancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Poly(adenosine diphosphate ribose) polymerase (PARP) is recruited to DNA damage sites along with epigenetic factors such as DNA methyltransferase 1 (DNMT1). Inhibitors of DNMT modulate reactive oxygen species (ROS)‐cyclic adenosine monophosphate (cAMP)/Protein Kinase A signaling and induce a “BRCAness phenotype” that further ...
Kathy D. Miller   +14 more
wiley   +1 more source

Cytidine and dCMP Deaminases-Current Methods of Activity Analysis. [PDF]

open access: yesInt J Mol Sci
Ligasová A   +4 more
europepmc   +1 more source

Effective Reduction in Nuclear DNA Contamination Allows Sensitive Mitochondrial DNA Methylation Determination by LC-MS/MS. [PDF]

open access: yesInt J Mol Sci
Liang L   +10 more
europepmc   +1 more source

Targeting the Rift Valley Fever Virus Polymerase: Resistance Mechanisms and Structural Insights. [PDF]

open access: yesACS Infect Dis
Král' M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy